Enovix Q3 Guidance: Sales, EPS Miss Analyst Estimates
Enovix (NASDAQ: ENVX) reported Q3 guidance below analyst estimates. Adjusted EPS is projected at $(0.17)-$(0.13) vs $(0.14) estimate. Sales are seen at $9M-$10M vs $10.252M estimate, indicating potential headwinds in near-term commercialization.

*this image is generated using AI for illustrative purposes only.
Enovix (NASDAQ: ENVX) has provided financial guidance for its third quarter that falls below analyst expectations for both earnings per share and revenue. The battery technology firm outlined a range for adjusted EPS and sales that suggests operational pressures or slower-than-anticipated commercial traction during the period.
The company forecasts adjusted EPS to fall between $(0.17) and $(0.13). This range represents a miss against the consensus analyst estimate of $(0.14), indicating that the upper bound of the guidance is less negative than expected, while the lower bound signals deeper losses than the market had priced in.
On the top line, Enovix sees sales ranging from $9.000 million to $10.000 million. This projection misses the analyst estimate of $10.252 million, with the entire guided range falling short of the consensus view on revenue generation.
What the Numbers Show
The divergence between the guided ranges and estimates highlights uncertainty in Enovix’s near-term execution. While the midpoint of the EPS guidance ($(0.15)) is slightly more negative than the estimate ($(0.14)), the revenue miss is more uniform, as even the high end of the sales guidance ($10.000 million) fails to reach the estimated $10.252 million. This suggests that revenue conversion may be lagging behind prior market assumptions.
What specific operational bottlenecks or supply chain issues are driving the uniform revenue miss across the entire guidance range?
How will Enovix adjust its capital expenditure strategy to manage cash burn given the deeper-than-expected losses in the lower bound of EPS guidance?
Are there indications that customer adoption cycles for silicon-anode batteries are lengthening, and how might this impact Q4 revenue projections?


























